Login / Signup

Hydroxychloroquine Dose and Hospitalizations for Active Lupus.

Jacquelyn NestorHyon ChoiChristian ManciniBaijun ZhouYuqing ZhangKaren H CostenbaderApril M Jorge
Published in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
The use of lower doses of HCQ was associated with an increased risk of hospitalizations for active SLE. Although the long-term risk of HCQ retinopathy must be acknowledged, this must be balanced with the short-term and cumulative risks of increased SLE activity.
Keyphrases
  • systemic lupus erythematosus
  • disease activity
  • rheumatoid arthritis
  • human health
  • risk assessment
  • climate change